These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 9162299)
1. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples. Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Levine N; Grogan T Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):343-8. PubMed ID: 9162299 [TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270 [TBL] [Abstract][Full Text] [Related]
3. Reproducibility and expression of skin biomarkers in sun-damaged skin and actinic keratoses. Einspahr JG; Xu MJ; Warneke J; Saboda K; Ranger-Moore J; Bozzo P; Duckett L; Goldman R; Lin P; Buckmeier J; Alberts DS Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1841-8. PubMed ID: 17021352 [TBL] [Abstract][Full Text] [Related]
4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin. Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114 [TBL] [Abstract][Full Text] [Related]
6. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. Einspahr JG; Nelson MA; Saboda K; Warneke J; Bowden GT; Alberts DS Clin Cancer Res; 2002 Jan; 8(1):149-55. PubMed ID: 11801552 [TBL] [Abstract][Full Text] [Related]
7. Clinical recognition of actinic keratoses in a high-risk population: how good are we? Venna SS; Lee D; Stadecker MJ; Rogers GS Arch Dermatol; 2005 Apr; 141(4):507-9. PubMed ID: 15837871 [TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Carpenter PM; Linden KG; McLaren CE; Li KT; Arain S; Barr RJ; Hite P; Sun JD; Meyskens FL Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):1996-2002. PubMed ID: 15598753 [TBL] [Abstract][Full Text] [Related]
9. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553 [TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness? Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion. Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432 [TBL] [Abstract][Full Text] [Related]
13. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma. Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668 [TBL] [Abstract][Full Text] [Related]
14. Actinic keratosis is squamous cell carcinoma. Lober BA; Lober CW South Med J; 2000 Jul; 93(7):650-5. PubMed ID: 10923948 [TBL] [Abstract][Full Text] [Related]
15. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers. Khuri FR; Lee JS; Lippman SM; Lee JJ; Kalapurakal S; Yu R; Ro JY; Morice RC; Hong WK; Hittelman WN Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):311-8. PubMed ID: 11319170 [TBL] [Abstract][Full Text] [Related]
16. Actinic keratoses: non-invasive diagnosis for field cancerisation. Ulrich M; Maltusch A; Röwert-Huber J; González S; Sterry W; Stockfleth E; Astner S Br J Dermatol; 2007 May; 156 Suppl 3():13-7. PubMed ID: 17488401 [TBL] [Abstract][Full Text] [Related]
17. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF; Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202 [TBL] [Abstract][Full Text] [Related]